Prestigious U.S professional recognition marks a major milestone for the innovative, scientifically developed toenail repair and recovery product
Aberdeen, U.K – 10th November 2026. – NovaBiotics Consumer Health Ltd, a UK-based innovator in scientifically developed nail health products and part of the NovaBiotics Group, is delighted to announce that its professional toenail repair and recovery product, Tinexyl® PRO, has been awarded the American Podiatric Medical Association (APMA) Seal of Approval.
The APMA Seal of Approval is a highly regarded recognition within the U.S podiatric medical community, awarded to products that meet the Association’s established criteria for promoting foot health.
The award represents a significant milestone for Tinexyl® PRO, providing independent professional recognition in the world’s largest podiatry market and reinforcing NovaBiotics Consumer Health’s commitment to bringing scientifically developed, innovative products to podiatrists and their patients.
Tinexyl® PRO is a first of its kind product for toenail health and offers podiatrists a new approach to the ongoing management of a range of challenging, clinically unmet nail conditions and can be used on its own or to complement other clinical treatments and managed professional care
Dr Deborah O’Neil OBE FRSE, CEO of NovaBiotics Consumer Healthcare commented, “We are extremely proud that Tinexyl PRO has received the American Podiatric Medical Association’s Seal of Approval. This is an important achievement for NovaBiotics Consumer Health and a significant endorsement of our approach to developing innovative, science-led products that address common but often inadequately managed nail health problems.
“Tinexyl® PRO provides podiatrists with a new tool to help manage a number of toenail conditions and supports the repair and recovery of healthier toenails.
“Receiving the APMA Seal of Approval is an exciting milestone as we build awareness of Tinexyl® PRO among podiatrists internationally, particularly in the United States.”
ENDS
About Tinexyl® PRO
Tinexyl® PRO has been designed specifically for use within professional podiatry and foot health practices, where it can be incorporated into individualised treatment and toenail management plans. It is a clear, colourless solution (free or urea, fragrance and chemical preservatives), applied by the podiatrist in clinic initially and then once-daily, at home, by the patient until the next clinic review. Duration of application to treat the toenail issue is for around 3 months in the first instance but then continued long-term maintenance use by the patients once the nail plate starts to improve and maintains the healthy toenail.
By improving the colour, texture, structure and strength of compromised toenails, Tinexyl® PRO provides an opportunity for podiatrists to extend their treatment offering beyond conventional approaches and support patients with longer-term nail care.
Tinexyl® PRO is a water-based product containing proprietary TXYL® polymers as well as humectants and debriding agents. Tinexyl® PRO conditions and hydrates the toenail. It is safe for use in diabetic patients, children over 5 years of age, pregnant and breast-feeding women.
The product can be used on its own for conditions such as ingrown toenails and nail plate changes due to onychauxis, trauma, inflammatory disease and also alongside appropriate antifungal treatments in onychomycosis where fungal infection is present, helping address the condition of the damaged nail plate while the underlying infection is treated.
About NovaBiotics Consumer Health Ltd
NovaBiotics Consumer Health Ltd develops innovative, science-led consumer and professional health products, applying expertise in biotechnology and product development to address common health and personal care challenges.
Media Enquiries
NovaBiotics Consumer Health Ltd
Aberdeen, Scotland, United Kingdom
Website: www.tinexylpro.com www.novabiotics.co.uk
Email: info@tinexylpro.com
Telephone: ++ 44 (0)1224 711377
About the American Podiatric Medical Association
The American Podiatric Medical Association (APMA) is a leading professional organisation representing doctors of podiatric medicine in the United States.
Its Seal of Approval programme recognises products that have been evaluated against established criteria relevant to foot health and their intended use.
For further information about the APMA, visit www.apma.org.
Recent Comments